IP Library › Granted Patent US 11,117,808
Granted Patent B2
US 11,117,808 · App. 16/051,812 · Granted Sep 14, 2021

Mesoporous nitric oxide-releasing silica particles, methods of making, and uses thereof

Inventors: Hitesh Handa (Athens, GA); Marcus Goudie (Athens, GA); Jitendra Pant (Athens, GA); Bryan Grommersch (Alpharetta, GA); Sean Hopkins (Athens, GA)
Assignee: University of Georgia Research Foundation, Inc.
C01B33/149A61L27/28A61L27/306A61L27/3637A61L27/54A61L27/56A61L29/08A61L29/106A61L29/146A61L29/16A61L31/08A61L31/088A61L31/146A61L31/16A61L2300/114A61L2420/04C01P2002/82C01P2004/03C01P2004/61C01P2006/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,117,808
App. No.
16/051,812
Granted
Sep 14, 2021
Kind
B2
Abstract

Nitric oxide-releasing materials, methods of making nitric oxide-releasing materials, and uses of nitric oxide-releasing materials are provided. The nitric oxide-releasing materials include a mesoporous silica core and an outer surface having a plurality of nitric oxide donors. In an exemplary aspects, the nitric oxide-releasing material includes a mesoporous diatomaceous earth core, and an outer surface having a plurality of S-nitroso-N-acetyl-penicillamine groups covalently attached thereto. Uses of the nitric oxide-releasing materials can include coatings for medical devices such as catheters, grafts, and stents; wound gauzes; acne medications; and antiseptic mouthwashes; among others.

Claims (16)

1. A nitric oxide-releasing material comprising:

a mesoporous diatomaceous earth core having an outer surface with an aminosilane covalently bonded to the outer surface, wherein the aminosilane is covalently bonded to the outer surface of the mesoporous diatomaceous earth core by a silicon atom of the aminosilane; and

a S-nitroso-N-acetyl-penicillamine group covalently bonded to the amino group of the aminosilane,

wherein the S-nitroso-N-acetyl-penicillamine group covalently bonded to the amino group of the aminosilane has the following formula

where A is the S-nitroso-N-acetyl-penicillamine group;

where R 1 is a substituted or unsubstituted C 1 -C 20 alkyl, a substituted or unsubstituted C 1 -C 20 heteroalkyl, a substituted or unsubstituted C 2 -C 20 alkenyl, a substituted or unsubstituted C 2 -C 20 herteroalkenyl, a substituted or unsubstituted C 1 -C 20 alkoxy, or a substituted or unsubstituted C 1 -C 20 heteroalkoxy;

where each occurrence of R 2 is independently a substituted or unsubstituted C 1 -C 20 alkyl, a substituted or unsubstituted C 1 -C 20 heteroalkyl, a substituted or unsubstituted C 2 -C 20 alkenyl, a substituted or unsubstituted C 2 -C 20 herteroalkenyl, a substituted or unsubstituted C 1 -C 20 alkoxy, a substituted or unsubstituted C 1 -C 20 heteroalkoxy, or a bond to an oxygen atom on the outer surface of the mesoporous diatomaceous earth core wherein at least one occurrence of R 2 is a bond to an oxygen atom on the outer surface of the mesoporous diatomaceous earth core.

2. The nitric oxide-releasing material according to claim 1 , wherein the nitric oxide-releasing material has a nitric oxide content of about 0.025 μmol to about 0.05 μmol per mg of the nitric oxide-releasing material.

3. The nitric oxide-releasing material according to claim 1 , wherein the nitric oxide-releasing material has a half-life for nitric oxide release of about 20 hours to about 40 hours.

4. The nitric oxide-releasing material according to claim 1 , wherein the nitric oxide-releasing material has an average pore size of about 300 nm to about 600 nm.

5. The nitric oxide-releasing material according to claim 1 , wherein the nitric oxide-releasing material is a particle having a longest dimension of about 10 μm to about 20 μm.

6. The nitric oxide-releasing material according claim 1 , wherein R 1 is a substituted or unsubstituted C 1 -C 12 alkyl.

7. The nitric oxide-releasing material according claim 1 , wherein the aminosilane is 3-aminopropyl)triethoxysilane (APTES), N-(6-aminohexyl)aminomethyltriethoxysilane (AHAMTES), or 3-aminopropyldimethylethoxysilane (APDMES).

8. The nitric oxide-releasing material according claim 1 , wherein the aminosilane is 3-aminopropyl)triethoxysilane (APTES).

9. A medical device having at least one surface, wherein the surface comprises the nitric oxide-releasing material having a structure according to claim 1 .

10. The medical device according to claim 9 , wherein the medical device is a urinary catheter, a vascular catheter, a graft, a stent, or a hydrogel strip.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE MISSING PAGE 2 PREVIOUSLY RECORDED ON REEL 48187 FRAME 89. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Apr 4, 2024
From: HANDA, HITESH; GOUDIE, MARCUS; PANT, JITENDRA; HOPKINS, SEAN; GROMMERSCH, BRYAN
To: UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
Reel/Frame 067019/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2019
From: HANDA, HITESH; GOUDIE, MARCUS; PANT, JITENDRA; HOPKINS, SEAN; GROMMERSCH, BRIAN
To: UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.
Reel/Frame 048187/0089 →
CONFIRMATORY LICENSE Recorded Dec 17, 2018
From: UNIVERSITY OF GEORGIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 049016/0623 →
Continuity (2)
Provisional Application 62539788 · Aug 1, 2017
Related Publication 20190039910A1 · Feb 7, 2019